Marc D. de Smet, MD, PhD

e:[email protected]

De Smet is director of MIOS in Lausanne, Switzerland (www.retina-uveitis.eu), and medical director of Preceyes Medical Robotics (www.preceyes.nl) in Eindhoven, The Netherlands.

Articles by Marc D. de Smet, MD, PhD

Managing neovascular retinal disease in COVID-19 era requires careful approach

ByMarc D. de Smet, MD, PhD,Marco Mura, MD

April 7th 2021

Minimizing clinic visits, maximizing use of imaging modalities are key.

Latest Updated Articles

Managing neovascular retinal disease in COVID-19 era requires careful approach
Published: April 7th 2021 | Updated:

Marc D. de Smet, MD, PhD

Articles by Marc D. de Smet, MD, PhD

Managing neovascular retinal disease in COVID-19 era requires careful approach

Latest Updated Articles

Trending on Ophthalmology Times - Clinical Insights for Eye Specialists

Sharper vision starts here

Oculis to launch PIONEER trials for privosegtor in acute optic neuritis and NAION

iOpeners: Zubair Ansari, MD, shares his global health journey with Nicole Bajic, MD

Study finds retinal progenitor cell injections improve outcomes in rat model of diabetic retinopathy

Q&A: What is the value of the YOURS program at EURETINA?